Jiangsu Nanfang Medical Co., Ltd. (SHA:603880)
China · Delayed Price · Currency is CNY 7.74
+0.03 (0.39%)
May 8, 2026, 3:00 PM CST
Jiangsu Nanfang Medical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -98.29 | -101.12 | -190.67 | -147.42 | -14.65 | -22.76 |
Depreciation & Amortization | 45.25 | 45.25 | 50.44 | 54.67 | 41.61 | 29.04 |
Other Amortization | 1.64 | 1.64 | 4.62 | 2.31 | 2.7 | 1.59 |
Loss (Gain) From Sale of Assets | - | - | -0.26 | 2.9 | -0.02 | -0.05 |
Asset Writedown & Restructuring Costs | 9.37 | 9.37 | 38.87 | 35.55 | 0.05 | 2.48 |
Loss (Gain) From Sale of Investments | -9.52 | -9.52 | -8.22 | -9.29 | -8.59 | -7.65 |
Provision & Write-off of Bad Debts | - | - | -16.53 | 29.89 | 4.43 | 4.58 |
Other Operating Activities | 66.61 | 34.43 | 40.21 | 54.37 | 25.31 | 34.59 |
Change in Accounts Receivable | -7.63 | -7.63 | 56.23 | -23.24 | -33.77 | -16.84 |
Change in Inventory | 40.95 | 40.95 | 63.88 | -0.38 | -76.84 | -113.14 |
Change in Accounts Payable | 26.53 | 26.53 | 35.51 | 17.74 | 105.62 | 2.79 |
Change in Other Net Operating Assets | - | - | - | - | - | 10.97 |
Operating Cash Flow | 82.73 | 47.73 | 63.32 | 15.51 | 31.28 | -84.25 |
Operating Cash Flow Growth | 4.64% | -24.62% | 308.27% | -50.41% | - | - |
Capital Expenditures | -15.45 | -13.2 | -32.41 | -66.16 | -146.16 | -211.75 |
Sale of Property, Plant & Equipment | - | - | 0.42 | 0.94 | 0.07 | 0.09 |
Divestitures | -1.74 | -1.74 | - | - | - | - |
Investment in Securities | 1.49 | 1.49 | - | - | - | -20 |
Other Investing Activities | 7.54 | 7.54 | 6.85 | 48.87 | 96.7 | 6.28 |
Investing Cash Flow | -8.16 | -5.91 | -25.14 | -16.35 | -181.42 | -225.38 |
Long-Term Debt Issued | - | 570.14 | 556.5 | 602.53 | 980.94 | 792.25 |
Total Debt Issued | 557.58 | 570.14 | 556.5 | 602.53 | 980.94 | 792.25 |
Long-Term Debt Repaid | - | -610.83 | -553.01 | -638.61 | -836.8 | -619.06 |
Total Debt Repaid | -597.8 | -610.83 | -553.01 | -638.61 | -836.8 | -619.06 |
Net Debt Issued (Repaid) | -40.22 | -40.69 | 3.49 | -36.08 | 144.14 | 173.18 |
Repurchase of Common Stock | - | - | - | - | - | -1.41 |
Common Dividends Paid | -26.19 | -25.9 | -27.08 | -21.63 | -18.6 | -47.09 |
Other Financing Activities | -0.43 | -0.43 | -18.6 | - | - | - |
Financing Cash Flow | -66.84 | -67.02 | -42.19 | -57.71 | 125.53 | 124.68 |
Foreign Exchange Rate Adjustments | -0.66 | 0.56 | 1.43 | -0.18 | -0.85 | -3.76 |
Net Cash Flow | 7.08 | -24.64 | -2.58 | -58.74 | -25.45 | -188.72 |
Free Cash Flow | 67.28 | 34.53 | 30.92 | -50.65 | -114.88 | -296.01 |
Free Cash Flow Growth | 18.07% | 11.71% | - | - | - | - |
Free Cash Flow Margin | 11.51% | 5.75% | 5.13% | -8.44% | -21.07% | -56.12% |
Free Cash Flow Per Share | 0.23 | 0.12 | 0.10 | -0.17 | -0.39 | -1.04 |
Cash Income Tax Paid | 8.32 | 7.54 | -3.8 | 11.03 | -49.62 | 2.61 |
Levered Free Cash Flow | 96.39 | 69.27 | -16.4 | -30.85 | -126.45 | -232.72 |
Unlevered Free Cash Flow | 96.39 | 69.27 | 0.12 | -16.36 | -113.83 | -225.34 |
Change in Working Capital | 67.68 | 67.68 | 144.86 | -7.48 | -19.56 | -126.07 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.